Bococizumab Terminated Phase 3 Trials for Cardiovascular Disease (CVD) Prevention

Indications	Status	Purpose	Phase
DBCOND0057913 (Cardiovascular Disease (CVD))	Terminated	Prevention	3

clinicaltrials.gov Identifier	Title	Drugs
NCT01975376	The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects	Bococizumab (DB12456)
NCT01975389	The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects	Bococizumab (DB12456)